Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$8.83 - $17.61 $5,253 - $10,477
-595 Reduced 17.74%
2,759 $25,000
Q4 2022

Jun 14, 2023

BUY
$10.88 - $20.05 $6,473 - $11,929
595 Added 21.57%
3,354 $38.3 Million
Q3 2022

Jun 14, 2023

BUY
$16.06 - $26.39 $9,555 - $15,702
595 Added 21.57%
3,354 $57.1 Million
Q2 2022

Jun 20, 2023

BUY
$20.49 - $39.72 $12,191 - $23,633
595 Added 21.57%
3,354 $72,000
Q1 2022

Jun 20, 2023

BUY
$28.19 - $46.6 $16,773 - $27,727
595 Added 21.57%
3,354 $124,000
Q1 2022

Mar 30, 2023

SELL
$28.19 - $46.6 $280,152 - $463,110
-9,938 Reduced 74.77%
3,354 $124,000
Q1 2022

May 12, 2022

SELL
$28.19 - $46.6 $280,152 - $463,110
-9,938 Reduced 74.77%
3,354 $124,000
Q4 2021

Jun 21, 2023

BUY
$41.2 - $73.6 $433,959 - $775,228
10,533 Added 381.77%
13,292 $604,000
Q3 2021

Jun 21, 2023

BUY
$59.15 - $91.99 $623,026 - $968,930
10,533 Added 381.77%
13,292 $842,000
Q3 2021

Mar 30, 2023

SELL
$59.15 - $91.99 $29,397 - $45,719
-497 Reduced 3.6%
13,292 $842,000
Q3 2021

Nov 15, 2021

SELL
$59.15 - $91.99 $29,397 - $45,719
-497 Reduced 3.6%
13,292 $842,000
Q2 2021

Jun 21, 2023

BUY
$63.02 - $95.11 $695,110 - $1.05 Million
11,030 Added 399.78%
13,789 $1.26 Million
Q2 2021

Mar 30, 2023

BUY
$63.02 - $95.11 $31,068 - $46,889
493 Added 3.71%
13,789 $1.26 Million
Q2 2021

Aug 16, 2021

BUY
$63.02 - $95.11 $868,163 - $1.31 Million
13,776 Added 105969.23%
13,789 $1.26 Million
Q1 2021

Jun 26, 2023

BUY
$57.62 - $95.6 $607,141 - $1.01 Million
10,537 Added 381.91%
13,296 $905 Million
Q1 2021

Mar 30, 2023

SELL
$57.62 - $95.6 $17,458 - $28,966
-303 Reduced 2.23%
13,296 $905,000
Q1 2021

May 14, 2021

SELL
$57.62 - $95.6 $782,825 - $1.3 Million
-13,586 Reduced 99.9%
13 $905,000
Q4 2020

Jun 22, 2023

BUY
$41.43 - $77.09 $449,101 - $835,655
10,840 Added 392.9%
13,599 $985,000
Q3 2020

Jun 26, 2023

BUY
$30.88 - $37.94 $334,739 - $411,269
10,840 Added 392.9%
13,599 $515,000
Q2 2020

Jun 26, 2023

BUY
$18.95 - $35.43 $205,418 - $384,061
10,840 Added 392.9%
13,599 $481,000
Q1 2020

Jul 12, 2023

BUY
$13.94 - $28.25 $151,109 - $306,230
10,840 Added 392.9%
13,599 $296,000
Q4 2019

Jul 12, 2023

BUY
$19.24 - $28.41 $208,561 - $307,964
10,840 Added 392.9%
13,599 $293,000
Q3 2019

Jul 12, 2023

BUY
$20.03 - $40.08 $217,125 - $434,467
10,840 Added 392.9%
13,599 $307,000
Q3 2019

Mar 30, 2023

BUY
$20.03 - $40.08 $44,927 - $89,899
2,243 Added 19.75%
13,599 $307,000
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $44,927 - $89,899
2,243 Added 19.75%
13,599 $307,000
Q2 2019

Jul 12, 2023

BUY
$25.78 - $39.77 $233,979 - $360,952
9,076 Added 328.96%
11,835 $425,000
Q1 2019

Jul 13, 2023

BUY
$22.09 - $39.21 $189,907 - $337,088
8,597 Added 311.6%
11,356 $357,000
Q1 2019

Mar 30, 2023

BUY
$22.09 - $39.21 $176,764 - $313,758
8,002 Added 238.58%
11,356 $357,000
Q1 2019

May 16, 2019

SELL
$22.09 - $39.21 $426,403 - $756,870
-19,303 Reduced 62.96%
11,356 $357,000
Q1 2019

May 15, 2019

BUY
$22.09 - $39.21 $426,403 - $756,870
19,303 Added 169.98%
30,659 $1.79 Million
Q4 2018

Jul 13, 2023

BUY
$19.89 - $30.02 $170,994 - $258,081
8,597 Added 311.6%
11,356 $285,000
Q4 2018

Feb 14, 2019

BUY
$19.89 - $30.02 $176,404 - $266,247
8,869 Added 356.61%
11,356 $285,000
Q3 2018

Jul 13, 2023

BUY
$12.1 - $28.85 $104,023 - $248,023
8,597 Added 311.6%
11,356 $328 Million
Q3 2018

Nov 14, 2018

SELL
$12.1 - $28.85 $107,314 - $255,870
-8,869 Reduced 78.1%
2,487 $72,000
Q2 2018

Aug 15, 2018

BUY
$7.93 - $15.79 $90,053 - $179,311
11,356 New
11,356 $0

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.